Canadian Journal of Gastroenterology (Jan 2013)

Serum Aspartate Aminotransferase Level and Previous Histopathological Findings Enable Reduction of Protocol Liver Biopsies after Liver Transplantation for Hepatitis C

  • Tomohiro Tanaka,
  • George Therapondos,
  • Nazia Selzner,
  • Eberhard L Renner,
  • Leslie B Lilly

DOI
https://doi.org/10.1155/2013/904636
Journal volume & issue
Vol. 27, no. 3
pp. 131 – 136

Abstract

Read online

BACKGROUND: Hepatitis C virus (HCV) infection remains the leading indication for liver transplantation (LT) worldwide. Recurrent hepatitis C following LT is universal, and significant fibrosis (SF, Metavir fibrosis stage ≥2) apparent on protocol biopsy typically prompts antiviral therapy.